DICE Therapeutics, Inc.
DICEDelisted Aug 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645569
DICE Therapeutics, Inc. was delisted on Aug 9, 2023; its insiders filed their last Form 4 on Aug 9, 2023; 160 institutions reported holding it in 13F filings for Q2 2023, worth $2.12B in total; Fairfax Financial was the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in DICE Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 115
- +6 vs. Q4 2022
- Shares held
- 52.1M
- +4.61M (+9.7%) vs. Q4 2022
- Total value
- $1.49B
- +$12.1M (+0.8%) vs. Q4 2022
- New holders
- 19
- 44 more added
- Sold out
- 13
- 32 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DICE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 160 | $2.12B |
| Q1 2023 | 115 | $1.49B |
| Q4 2022 | 109 | $1.48B |
| Q3 2022 | 79 | $748.2M |
| Q2 2022 | 80 | $564.6M |
| Q1 2022 | 76 | $637.5M |
| Q4 2021 | 69 | $799.4M |
| Q3 2021 | 39 | $793.6M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding DICE Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Virtus ETF Advisers LLC | 2,980 | $85.4K | 0.05% | −1,147−27.8% | Reduced |
| Ameritas Investment Partners, Inc. | 2,832 | $81.1K | 0.00% | 00.0% | Unchanged |
| Amundi | 2,993 | $78.4K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 2,015 | $57.7K | 0.00% | −208−9.4% | Reduced |
| Royal Bank of Canada | 1,992 | $57.0K | 0.00% | −2,580−56.4% | Reduced |
| Tower Research Capital LLC (TRC) | 1,802 | $52.0K | 0.00% | +1,354+302.2% | Added |
| Ameritas Advisory Services, LLC | 1,000 | $28.6K | 0.00% | +1,000 | New |
| China Universal Asset Management Co., Ltd. | 646 | $18.5K | 0.01% | +162+33.5% | Added |
| Daiwa Securities Group Inc. | 192 | $6.00K | 0.00% | 00.0% | Unchanged |
| Toth Financial Advisory Corp | 50 | $1.43K | 0.00% | +50 | New |
| Red Tortoise LLC | 45 | $1.29K | 0.00% | +45 | New |
| Dark Forest Capital Management LP | 23 | $659 | 0.00% | +23 | New |
| Nisa Investment Advisors, LLC | 10 | $0 | 0.00% | −13−56.5% | Reduced |
| CWM, LLC | 6 | $0 | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −398,477−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −293,362−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −148,194−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −53,408−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −36,420−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −12,637−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −12,369−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −11,500−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −9,901−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −9,771−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −7,039−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,732−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −34−100.0% | Sold out |